Kenya - English - Pharmacy and Poisons Board

aurobindo pharma limited plot no. 11, survey 9, hitech city, hyderabad - abacavir sulfate usp - oral solution - abacavir sulfate 20 mg/ml - antivirals for systemic use:

Kenya - English - Pharmacy and Poisons Board

mylan laboratories limited c/o surgilinks ltd mylan laboratories limited r&d centre plot no. - abacavir sulfate usp lamivudine usp zidovudine usp - modified-release tablet - abacavir sulfate usp equivalent to abacavir 300mg… - antivirals for systemic use: combinations of

Kenya - English - Pharmacy and Poisons Board

cipla limited cipla house, peninsula business park, ganpatrao - abacavir tablets usp 300 - tablet - abacavir sulphate usp equivalent to abacavir 300mg - antivirals for systemic use:

Kenya - English - Pharmacy and Poisons Board

mylan laboratories limited c/o surgilinks ltd mylan laboratories limited r&d center plot no. - abacavir sulfate usp - modified-release tablet - abacavir sulfate usp eq. to abacavir 30mg - antivirals for systemic use:

Kenya - English - Pharmacy and Poisons Board

mylan laboratories limited c/o surgilinks ltd r & d centre plot no. 34-a anrich industrial - abacavir sulfate usp - modified-release tablet - abacavir sulfate usp equivalent to abacavir 60 mg - antivirals for systemic use:

Kenya - English - Pharmacy and Poisons Board

cipla ltd cipla house, peninsula business park, ganpatrao - abacavir sulfate lamivudine lopinavir ritonavir - capsule - abacavir sulfate usp equivalent to… - antivirals for systemic use: combinations of

Canada - English - Health Canada

apotex inc - abacavir (abacavir sulfate); lamivudine - tablet - 600mg; 300mg - abacavir (abacavir sulfate) 600mg; lamivudine 300mg - nucleoside and nucleotide reverse transcriptase inhibitors

Canada - English - Health Canada

apotex inc - abacavir (abacavir sulfate); lamivudine - tablet - 600mg; 300mg - abacavir (abacavir sulfate) 600mg; lamivudine 300mg - nucleoside and nucleotide reverse transcriptase inhibitors

Australia - English - Department of Health (Therapeutic Goods Administration)

viiv healthcare pty ltd - abacavir sulfate, quantity: 702 mg (equivalent: abacavir, qty 600 mg); lamivudine, quantity: 300 mg; dolutegravir, quantity: 50 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; sodium starch glycollate; povidone; magnesium stearate; purified water; mannitol; titanium dioxide; purified talc; iron oxide red; polyvinyl alcohol; macrogol 3350; iron oxide black - triumeq is indicated for the treatment of human immunodeficiency virus (hiv) infection in adults and adolescents from 12 years of age who are antiretroviral treatment-na?ve or are infected with hiv without documented or clinically suspected resistance to any of the three antiretroviral agents (dolutegravir, abacavir or lamivudine) in triumeq.

Malta - English - Medicines Authority

actavis group ptc ehf - abacavir; lamivudine - film-coated tablet - abacavir 600 mg; lamivudine 300 mg - antivirals for systemic use